Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2023-06-14 Board/Management Inform…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Sisäpiiritieto: Optomed julkaisee toimitusjohtajan vaihdossuunnitelman
Board/Management Information Classification · 100% confidence The document is a short announcement from Optomed Oyj, explicitly labeled as 'Sisäpiiritieto' (Inside Information) and dated June 14, 2023. The content details the planned departure of the CEO (Seppo Kopsala) and the initiation of a search for a new CEO. This type of announcement, concerning changes in senior management, directly corresponds to the definition of 'Board/Management Information'. The document length is short (2411 characters), but it is the primary announcement itself, not merely an announcement *about* a report, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule for this specific content type. Therefore, the classification is MANG.
2023-06-14 Finnish
Inside information: Optomed announces CEO transition plan
Board/Management Information Classification · 100% confidence The document is a short announcement titled "Inside information: Optomed announces CEO transition plan." It details the departure agreement between the current CEO, Seppo Kopsala, and the Board of Directors, and mentions the initiation of a search for a new CEO. This content directly relates to changes in senior management personnel. Based on the definitions, this aligns perfectly with the Board/Management Information category (MANG). The document length is short (2241 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA/RNS is not the primary classification.
2023-06-14 English
Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta
Major Shareholding Notification Classification · 100% confidence The document is a formal notification regarding a change in shareholding (flagging notification) under the Finnish Securities Markets Act (Arvopaperimarkkinalaki). It details the reduction of ownership by Cenova Capital in Optomed Oyj, providing specific percentage breakdowns of shares and voting rights. This fits the definition of a Major Shareholding Notification (MRQ).
2023-06-05 Finnish
Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta
Major Shareholding Notification Classification · 99% confidence The document is a formal notification from Optomed Oyj regarding a change in major shareholding, specifically citing the Finnish Securities Markets Act (Arvopaperimarkkinalain 9 luvun 10 §). It details the percentage change in ownership by Cenova Capital's funds, dropping from 14.36% to 9.96%. This type of filing, which reports changes in significant share ownership crossing regulatory thresholds, directly corresponds to the 'Major Shareholding Notification' category. Document length (4383 chars) is moderate, but the content is a specific regulatory disclosure, not a general announcement of a report release (RPA/RNS).
2023-06-05 Finnish
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Major Shareholding Notification Classification · 98% confidence The document is titled 'Optomed Oyj - Major shareholder announcements' and explicitly mentions 'Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings'. It details a change in the percentage of shares and voting rights held by a specific entity (Cenova Capital) crossing a threshold. This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is a formal regulatory disclosure, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2023-06-05 English
Optomedin varsinaisen yhtiökokouksen ja hallituksen päätöksiä
AGM Information Classification · 100% confidence The document is an official announcement detailing the decisions made at Optomed's Annual General Meeting (AGM) held on May 10, 2023. It covers the approval of financial statements, board member elections, remuneration policies, and authorizations for share issues and buybacks. While it contains information about voting results, it is a comprehensive summary of the meeting's outcomes rather than just a raw vote count, and it fits the definition of AGM-R (Annual General Meeting materials/decisions).
2023-05-10 Finnish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.